AC
ARNA

Apogem Capital’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Apogem Capital’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,378
Closed -$314K – 204
2021
Q4 		$314K Sell
3,378
-8,663
-72% -$571K 0.21% 133
2021
Q3 		$717K Buy
12,041
+1,647
+16% +$97.3K 0.46% 88
2021
Q2 		$709K Buy
10,394
+2,278
+28% +$148K 0.45% 81
2021
Q1 		$563K Sell
8,116
-926
-10% -$71.3K 0.38% 83
2020
Q4 		$695K Buy
+9,042
New +$678K 0.46% 72

Apogem Capital's ARNA Position: Q1 2022 in Review

Apogem Capital sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 3,378 shares — an estimated $314K sold.

Apogem Capital first reported a position in ARNA in Q4 2020 and held it in 5 quarters. The position peaked at $717K in Q3 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Apogem Capital reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Apogem Capital sold 3,378 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $314K.
  • Apogem Capital first reported a position in Arena Pharmaceuticals Inc in Q4 2020 and held it in 5 quarters.
  • Apogem Capital's Arena Pharmaceuticals Inc position peaked at $717K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Apogem Capital's 13F filing for Q1 2022, filed 16 May 2022.